Literature DB >> 8442640

[Development, equilibrium and role of microbial flora in the newborn].

R Ducluzeau1.   

Abstract

Development of the digestive tract intestinal flora is the result of a specific selection process to which the multiple maternal or environmental bacteria that penetrate into the neonatal gut are subjected. In breast-fed infants, Escherichia coli and streptococci are the first bacteria to appear in the gut. They are usually, but not always, followed by a population of Bifidobacterium which quickly becomes predominant. In bottle-fed infants, the intestinal flora is more variable and often includes, in addition to the organisms mentioned above, other enterobacteria and a wider range of obligate anaerobes. Studies of experimental models have shown that the nature of milk fed to the offspring and even the lactating mother's diet have substantial effects on the sequence of development of the neonatal intestinal flora. A large number of factors capable of inhibiting or permitting in vitro growth of various bacterial species have been identified in milk. However, no in vitro activity of these factors added to milk has ever been demonstrated. These factors include "bifidus factors", which promotes the growth of Bifidobacterium, and lactoferrin and immunoglobulins, which prevent colonisation of the gut by pathogenic enterobacteria. Immune factors in milk play a key role in interactions between the microbial flora and gut mucosa. However, they seem to have no effect on the growth of bacterial populations in the gut lumen. A number of pioneer bacteria, which are the first to arrive in the gut, are capable of effectively blocking growth of other bacteria introduced later in the ecosystem. In some instances, these pioneer bacteria also inhibit production of toxins by pathogenic species. Consequently, it is important to adhere to the recommended gradual changes in diet which allow these species to sequentially colonize the gut.

Entities:  

Mesh:

Year:  1993        PMID: 8442640

Source DB:  PubMed          Journal:  Ann Pediatr (Paris)        ISSN: 0066-2097


  6 in total

Review 1.  Necrotising enterocolitis and localised intestinal perforation: different diseases or ends of a spectrum of pathology.

Authors:  V E Boston
Journal:  Pediatr Surg Int       Date:  2006-05-04       Impact factor: 1.827

Review 2.  Do probiotics have a therapeutic role in gastroenterology?

Authors:  Jimmy K Limdi; Catherine O'Neill; John McLaughlin
Journal:  World J Gastroenterol       Date:  2006-09-14       Impact factor: 5.742

3.  Molecular characterization of bacterial colonization in the preterm and term infant's intestine.

Authors:  J C Hallab; S T Leach; L Zhang; H M Mitchell; J Oei; K Lui; A S Day
Journal:  Indian J Pediatr       Date:  2012-05-11       Impact factor: 1.967

4.  "Enhanced acquisition of antibiotic-resistant intestinal E. coli during the first year of life assessed in a prospective cohort study".

Authors:  Dorothea Orth-Höller; Reinhard Würzner; Martina Prelog; Peninnah Oberdorfer; Benjamin Hetzer; Peter Kreidl; Michaela Lackner; Thomas Müller; Ludwig Knabl; Daniel Rudolf Geisler-Moroder; Alexander Mellmann; Özcan Sesli; Jeanett Holzknecht; Damia Noce; Orawan Boonpala; Noppadon Akarathum; Somporn Chotinaruemol
Journal:  Antimicrob Resist Infect Control       Date:  2019-05-20       Impact factor: 4.887

5.  Identifying the Sources of Intestinal Colonization With Extended-Spectrum β-Lactamase-Producing Escherichia coli in Healthy Infants in the Community.

Authors:  Mohammed Badrul Amin; Kazi Injamamul Hoque; Subarna Roy; Sumita Rani Saha; Md Rayhanul Islam; Timothy R Julian; Mohammad Aminul Islam
Journal:  Front Microbiol       Date:  2022-03-31       Impact factor: 5.640

6.  Effect of oral application of a probiotic E. coli strain on the intestinal microflora of children of allergic mothers during the first year of life.

Authors:  I Kocourková; R Žádníková; J Žižka; V Rosová
Journal:  Folia Microbiol (Praha)       Date:  2007       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.